Show simple item record

dc.contributor.authorŠakalytė, Regina
dc.contributor.authorDenkovskij, Jaroslav
dc.contributor.authorBernotienė, Eiva
dc.contributor.authorStropuvienė, Sigita
dc.contributor.authorMikulėnaitė, Silvija Ona
dc.contributor.authorKvederas, Giedrius
dc.contributor.authorPorvaneckas, Narūnas
dc.contributor.authorTutkus, Vytautas
dc.contributor.authorVenalis, Algirdas
dc.contributor.authorButrimienė, Irena
dc.date.accessioned2023-09-18T16:16:57Z
dc.date.available2023-09-18T16:16:57Z
dc.date.issued2022
dc.identifier.other(SCOPUS_ID)85124032368
dc.identifier.urihttps://etalpykla.vilniustech.lt/handle/123456789/112686
dc.description.abstractActivated rheumatoid arthritis (RA) synovial fibroblasts (SFs) are among the most important cells promoting RA pathogenesis. They are considered active contributors to the initiation, progression, and perpetuation of the disease; therefore, early detection of RASF activation could advance contemporary diagnosis and adequate treatment of undifferentiated early inflammatory arthritis (EA). In this study, we investigated the expression of nucleotide-binding, oligomerization domain (NOD)-like receptor family, pyrin domain containing (NLRP)1, NLRP3 inflammasomes, Toll-like receptor (TLR)1, TLR2, TLR4, vitamin D receptor (VDR), and secretion of matrix metalloproteinases (MMPs) in SFs isolated from patients with RA, osteoarthritis (OA), EA, and control individuals (CN) after knee surgical intervention. C-reactive protein, general blood test, anticyclic citrullinated peptide (anti-CCP), rheumatoid factor (RF), and vitamin D (vitD) in patients’ sera were performed. Cells were stimulated or not with 100 ng/ml tumor necrosis factor alpha (TNF-α) or/and 1 nM or/and 0.01 nM vitamin D3 for 72 h. The expression levels of NLRP1, NLRP3, TLR1, TLR2, TLR4, and VDR in all examined SFs were analyzed by quantitative real-time PCR (RT-qPCR). Additionally, the secretion of IL-1β by SFs and MMPs were determined by ELISA and Luminex technology. The expression of NLRP3 was correlated with the levels of CRP, RF, and anti-CCP, suggesting its implication in SF inflammatory activation. In the TNF-α-stimulated SFs, a significantly lower expression of NLRP3 and TLR4 was observed in the RA group, compared with the other tested forms of arthritis. Moreover, upregulation of NLRP3 expression by TNF-α alone or in combination with vitD3 was observed, further indicating involvement of NLRP3 in the inflammatory responses of SFs. Secretion of IL-1β was not detected in any sample, while TNF-α upregulated the levels of secreted MMP-1, MMP-7, MMP-8, MMP-12, and MMP-13 in all patient groups. Attenuating effects of vitD on the expression of NLRP3, TLR1, and TLR4 suggest potential protective effects of vitD on the inflammatory responses in SFs. However, longer studies may be needed to confirm or fully rule out the potential implication of vitD in SF activation in inflammatory arthritis. Both VDR and NLRP3 in the TNF-α-stimulated SFs negatively correlated with the age of patients, suggesting potential age-related changes in the local inflammatory responses.eng
dc.formatPDF
dc.format.extentp. 1-15
dc.format.mediumtekstas / txt
dc.language.isoeng
dc.relation.isreferencedbyScopus
dc.relation.isreferencedbyScience Citation Index Expanded (Web of Science)
dc.source.urihttps://www.frontiersin.org/articles/10.3389/fimmu.2021.767512/full
dc.titleThe expression of inflammasomes NLRP1 and NLRP3, Toll-like receptors, and vitamin D receptor in synovial fibroblasts from patients with different types of knee arthritis
dc.typeStraipsnis Web of Science DB / Article in Web of Science DB
dcterms.references96
dc.type.pubtypeS1 - Straipsnis Web of Science DB / Web of Science DB article
dc.contributor.institutionVilniaus universitetas Valstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras
dc.contributor.institutionValstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras
dc.contributor.institutionValstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras Vilniaus Gedimino technikos universitetas
dc.contributor.institutionVilniaus universitetas
dc.contributor.facultyFundamentinių mokslų fakultetas / Faculty of Fundamental Sciences
dc.subject.researchfieldN 004 - Biochemija / Biochemistry
dc.subject.researchfieldN 010 - Biologija / Biology
dc.subject.researchfieldM 001 - Medicina / Medicine
dc.subject.vgtuprioritizedfieldsFM0202 - Ląstelių ir jų biologiškai aktyvių komponentų tyrimai / Investigations on cells and their biologically active components
dc.subject.ltspecializationsL105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies
dc.subject.enarthritis (including rheumatoid arthritis)
dc.subject.enToll-like receptor (TLR)
dc.subject.envitamin D
dc.subject.enmetalproteinase
dc.subject.enosteoarthristis
dc.subject.eninflammasome NLRP
dc.subject.enearly arthritis (EA)
dc.subject.enVDR
dcterms.sourcetitleFrontiers in immunology
dc.description.volumevol. 12
dc.publisher.nameFrontiers Media S.A.
dc.publisher.cityLausanne
dc.identifier.doi2-s2.0-85124032368
dc.identifier.doi85124032368
dc.identifier.doi1
dc.identifier.doi133882780
dc.identifier.doi000798025600001
dc.identifier.doi10.3389/fimmu.2021.767512
dc.identifier.elaba119828633


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record